Nymox Pharmaceutical (NYMXF) Live Share Price, Invest From India

Nymox Pharmaceutical Stock Performance

as on October 24, 2026 at 3:25 am IST

Day's Low
$0.04
Day's Price Range
$0.05
$0.05
20.00%
Downside
52 Week's Low
52 Week's High
52-Week Price Range
$0.05
100.00%
Downside
-100.00%
Upside

Nymox Pharmaceutical share price movements today

Previous Close: $0.06
Open: $0.04
Volume: 18.6K
Market Cap: $6.3M
Day's Low - High: $0.04 - $0.05

Nymox Pharmaceutical Historical Returns

1 Month Return: + 200 %
3 Month Return: + 500 %
1 Year Return: -45.5 %
3 Year Return: -94.03 %
5 Year Return: 0 %

Nymox Pharmaceutical Stock Fundamentals & Key Indicators

Check Nymox Pharmaceutical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3M

EPS (TTM)

-0.0091

Dividend Yield

0.00%

PE Ratio (TTM)

-1.35

Industry PE ratio

-5.17

PEG Ratio

-0.01

Return On Equity TTM

53.17%

Nymox Pharmaceutical stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Nymox Pharmaceutical with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Nymox Pharmaceutical	NA	$6.3M	NA	-1.35	0.00%	0.00%

Stock Returns calculator for Nymox Pharmaceutical Stock including INR - Dollar returns

The Nymox Pharmaceutical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Nymox Pharmaceutical investment value today

Current value as on today

₹49,118

Returns

-₹50,882

(-50.88%)

Returns from Nymox Pharmaceutical Stock

-₹54,587 (-54.59%)

Dollar Impact

₹3,705 (+3.7%)

Nymox Pharmaceutical Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	0	0	-	0	-
Operating Income	-3	-2	-5	-1	-1	-1	-1	-1	-4	0
EBITDA	-3	-	-5	-1	-1	-1	-1	-1	-5	0
Interest Expense	-	-	0	-	0	0	0	0	0	0
Depreciation	-	-	-	-	-	0	0	-	0	-
Income Before Tax	-3	-2	-5	1	-1	-1	-1	-1	-5	0
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-2	-5	1	-1	-1	-1	-1	-5	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nymox Pharmaceutical Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-13	-10	-13	-12	-6	-8	-4	-3
EBITDA	-13	-10	-13	-12	-6	-8	-4	-3
Interest Expense	0	0	0	0	0	0	0	0
Depreciation	-	-	-	0	0	0	0	0
Income Before Tax	-13	-10	-13	-12	-6	-8	-4	-4
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-13	-10	-13	-12	-6	-8	-4	-4
Net Profit Margin	33.04%	52.83%	42.24%	0.00%	0.00%	0.00%	0.00%	0.00%

Nymox Pharmaceutical Quarterly Cash Flow

All numbers in Millions USD

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Dec 2024
Net Income	-3	-2	-5	1	-1	-1	-1	-1	-5	0
Operating Cash Flow	-2	-2	-4	1	-1	0	0	-1	0	0
Investing Cash Flow	0	0	-	-	-	0	0	0	0	-
Financing Cash Flow	0	0	4	1	0	0	0	1	0	0
Change in Cash	-3	-2	0	3	-1	-1	0	0	0	0

Nymox Pharmaceutical Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Net Income	-13	-10	-13	-11	-12	-6	-8	-4	-4
Operating Cash Flow	-6	-7	-7	-10	-9	-5	-4	-2	-1
Investing Cash Flow	-	0	-	0	0	-	0	-	0
Financing Cash Flow	5	14	4	8	7	5	2	2	1
Change in Cash	-1	7	-2	-1	-2	0	1	0	0

About Nymox Pharmaceutical

Nymox Pharmaceutical Corporation is a biopharmaceutical firm focused on the research and development of medications for the aging population. Operating internationally, including in Canada, the United States, and Europe, the company's flagship drug candidate is Fexapotide Triflutate (NX-1207). This compound is currently undergoing various clinical trials for conditions such as benign prostatic hyperplasia and low-grade localized prostate cancer, with preclinical investigations also underway for hepatocellular carcinoma. Beyond its drug pipeline, Nymox develops and offers two diagnostic products: NicAlert, which identifies tobacco usage, and TobacAlert, designed to detect exposure to secondhand smoke. The company is also actively engaged in developing treatments for Alzheimer's disease. Nymox Pharmaceutical Corporation was established in 1989 and maintains its headquarters in Nassau, the Bahamas.

Organisation	Nymox Pharmaceutical
Headquarters	Bay & Deveaux Streets, Nassau, NW, H4M 2V2, BS
Industry	Biotechnology
CEO	Paul Averback

Key Management of Nymox Pharmaceutical

Name	Title
Dr. Paul Averback DABP, M.D.	Founder, Chairman, CEO & President
Ms. Lin Dodd	QA and Compliance Manager

FAQs

What is Nymox Pharmaceutical share price today?

Nymox Pharmaceutical share price today is $0.05 as on October 23, 2026 at 9:55 pm IST. Nymox Pharmaceutical share today touched a day high of $0.05 and a low of $0.04.

What is the 52 week high and 52 week low for Nymox Pharmaceutical share?

Nymox Pharmaceutical share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Nymox Pharmaceutical stock price today i.e. October 23, 2026 at 9:55 pm IST is trending at $0.05,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Nymox Pharmaceutical's market capitalisation today?

Nymox Pharmaceutical market capitalisation is $0.00T as on October 23, 2026 at 9:55 pm IST.

How to invest in Nymox Pharmaceutical Stock (NYMXF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nymox Pharmaceutical on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Nymox Pharmaceutical Stock (NYMXF) from India?

Indian investors can start investing in Nymox Pharmaceutical (NYMXF) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 1:12 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Nymox Pharmaceutical stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 1:12 am IST). Based on Nymox Pharmaceutical share’s latest price of $0.05 as on October 23, 2026 at 9:55 pm IST, you will get 200.0000 shares of Nymox Pharmaceutical. Learn more about fractional shares .